Y Han, W Huang, J Liu, D Liu, Y Cui, R Huang… - Theranostics, 2017 - ncbi.nlm.nih.gov
Enzalutamide is a second-generation androgen receptor (AR) antagonist for the treatment of
metastatic castration-resistant prostate cancer (mCRPC). Unfortunately, AR dysfunction …